Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FTI in CF Patients with Pseudomonas Aeruginosa
NCT00794586Phase 2Completed
- Sponsor
- Gilead Sciences
- Start
- Nov 2008
- Primary completion
- Feb 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fosfomycin + tobramycin in cystic fibrosis (CF), Pseudomonas aeruginosa lung infection, sponsored by Gilead Sciences. Started Nov 2008; status: completed.
02
Drugs
fosfomycin + tobramycin
03
Conditions
cystic fibrosis (CF)Pseudomonas aeruginosa lung infection
Beyond the preview
Go deeper on NCT00794586.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00794586.